Jeremy Grantham Abbott Laboratories Transaction History
Grantham, Mayo, Van Otterloo & Co. LLC
- $31.4 Billion
- Q3 2024
A detailed history of Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) transactions in Abbott Laboratories stock. As of the latest transaction made, Grantham, Mayo, Van Otterloo & Co. LLC holds 7,109,688 shares of ABT stock, worth $813 Million. This represents 2.59% of its overall portfolio holdings.
Number of Shares
7,109,688
Previous 5,792,160
22.75%
Holding current value
$813 Million
Previous $602 Million
34.68%
% of portfolio
2.59%
Previous 2.06%
Shares
30 transactions
Others Institutions Holding ABT
# of Institutions
3,186Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$19.2 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$15 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$8.77 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$7.52 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.09 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $200B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...